High body temperature may boost gut microbiota to fight viral infections

FHS
July 20, 2023
4:23 pm

Researchers from The University of Tokyo unravel the connection between high body temperature and increased viral resistance.

Merck KGaA abandons Phase III trial for $1.08bn head & neck cancer drug

Merck licenced xevinapant from Debiopharm International in 2021 in a deal worth $1.08bn. Image Credit: Anne Czichos / Shutterstock Merck KGaA (Merck) has discontinued the

June 25, 2024

Superagers’ brains resist age-related decline, study finds

Researchers explored brain white matter integrity in superagers, older adults with exceptional cognitive abilities, finding that while overall white matter health showed no significant differences,

May 9, 2024

Trump Taps Dr. Oz to Run CMS

President-elect Donald Trump says he is nominating Mehmet Oz, MD, a heart surgeon who hosted a long-running television talk show, to lead the Centers for

November 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.